Westfield Capital Management CO LP Bridge Bio Pharma, Inc. Transaction History

Westfield Capital Management CO LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$11.38 - $53.41 $5.41 Million - $25.4 Million	-474,976 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$46.87 - $64.24 $817,225 - $1.12 Million	17,436 Added 3.81%	474,976 $22.3 Million
Q2 2021 Aug 10, 2021	SELL	$46.47 - $63.93 $1.14 Million - $1.57 Million	-24,551 Reduced 5.09%	457,540 $27.9 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $7.5 Million - $9.78 Million	135,211 Added 38.98%	482,091 $29.7 Million
Q4 2020 Feb 12, 2021	BUY	$38.38 - $71.11 $13.3 Million - $24.7 Million	346,880 New	346,880 $24.7 Million

309

170M

10.6M

2.43M

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $4.68B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

Get notified when there are updates to the investment portfolio of Westfield Capital Management CO LP, based on Form 13F filings with the SEC.

Stay updated on Westfield Capital Management CO LP with notifications on news.